Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease

NCT01971593 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01971593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01971593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2013
Completion date
June 30, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

single ventricle with a fontan palliation, tetralogy of fallot, transposition of the great vessels with an arterial switch